S H Kelkar & Company Ltd Q4 FY25 Earnings Analysis

Published 28 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.9K Cr

Price

134

Market Cap

₹1.9K Cr

P/E Ratio

38.1

Earnings Summary

- Company targets a 12% CAGR growth over the mid to longer term, with recent 9-month performance ahead at nearly 17% YoY growth. - Expectation of reaching around Rs. - The company expects to maintain a healthy top-line growth of 12% CAGR over the mid to longer term, with FY25 ahead at ~17%.

📊 Revenue & Sales Performance

- Company targets a 12% CAGR growth over the mid to longer term, with recent 9-month performance ahead at nearly 17% YoY growth. - Expectation of reaching around Rs. 3,000 crore revenue by FY27, implying approximately 14% CAGR. - Major growth contribution expected from volume increases rather than price hikes. - Flavours business anticipated to grow at a strong +15% CAGR, faster than the more mature Fragrance business. - European business growing healthily at around 12% annually, outpacing the ~2% market average, with potential capacity expansion planned within 1-2 years. - New investments in development and production capacity across key geographies (Europe, US, SE Asia) to support higher growth from 18-24 months onwards. - Momentum in India remains robust (~15% YoY growth), with expected growth pickup in early FY26 due to government initiatives boosting consumption.

📈 Profitability & Margins

- The company expects to maintain a healthy top-line growth of 12% CAGR over the mid to longer term, with FY25 ahead at ~17%. - EBITDA margins excluding new geography investments stand at a healthy 17%, with an overall margin guidance of 16%-18% for the upcoming year, despite current subdued margins due to investments. - Gross margins are expected to normalize and improve over the next year as pricing actions take effect and raw material supply stabilizes. - Investments in Europe, US, and other markets are strategic for long-term growth, expected to drive higher market share, operating leverage, and sustained value creation over the next 3 years. - Flavours segment delivering strong EBIT (~22%) and growth, expected to contribute to margin expansion as growth accelerates. - Development expenditure (~Rs. 45-48 crore in FY25) will stabilize, with inflation-adjusted increases thereafter, supporting steady earnings growth. - Overall, earnings and EPS growth are expected to benefit from volume-driven revenue growth, margin expansion, and cost normalization.

🏗️ Capital Expenditure Plans

- The company has completed major investments in development and production capacities for its Flavours business and expects this phase to be finished for the current size. - Further investments in the Flavours business are anticipated in the next 2 years to support continued growth. - Recent investments include setting up creative development centers in Europe (UK and Germany) and the USA, focusing on product development teams to serve local and global MNC markets. - Capital expenditure of around Rs. 75 crore has been incurred for rebuilding a factory after a fire, expected to be reimbursed substantially through insurance. - The company invested approximately Rs. 45-48 crore in FY25 towards development centers and expects this cost to stabilize and grow only by inflation thereafter. - There are plans to invest in European production capacity within the next 1–2 years to support sales momentum and capacity utilization. - No plans to expand beyond the current four major markets (Southeast Asia, India, Middle East, Europe, and America) in the near to medium term.

💰 Fundraising & Capital Structure

- The transcript does not mention any current or planned fundraising through debt or equity. - The company is focusing on managing existing debt, which stood at Rs. 703 crore as of December 31, 2024. - Debt increase recently is attributed mainly to inventory replenishment post the Q1 fire incident, capital expenditure, and GST refund delays. - Management highlighted expectations of debt reduction by about Rs. 100 crore in the next 6 months, aided by insurance payouts. - Investments are ongoing but appear to be funded through internal accruals and existing debt facilities. - No explicit plans were shared regarding fresh debt or equity raising in the near or medium term during the Q3 & 9M FY25 concall.

📋 Order Book & Pipeline

- The transcript does not explicitly mention the exact current or expected order book or pending orders. - However, the company indicates strong demand and growth prospects despite some slowdown in larger Indian domestic accounts. - Kedar Vaze highlights a robust 15% year-on-year quarterly growth with no slowdown seen so far. - The business is gaining market share, especially in new geographies like Southeast Asia, Middle East, Europe, and the US. - New client engagements and product developments are ongoing, supporting a 12%-14% revenue growth guidance. - For the global MNC account, business is on track to reach $10 million this year, with expected growth of 20%-30% going forward. - Inventory replenishment and new investments suggest positive order fulfillment outlook, though precise order backlog figures are not disclosed.

Key Metrics

Frequently Asked Questions

What were S H Kelkar & Company Ltd Q4 FY25 results?

- Company targets a 12% CAGR growth over the mid to longer term, with recent 9-month performance ahead at nearly 17% YoY growth. - Expectation of reaching around Rs. - The company expects to maintain a healthy top-line growth of 12% CAGR over the mid to longer term, with FY25 ahead at ~17%.

What is S H Kelkar & Company Ltd share price analysis?

S H Kelkar & Company Ltd currently shows a neutral. The stock trades at a P/E of 38.1 with a market cap of ₹1,869. Investors should review the full earnings analysis for detailed insights.

Is S H Kelkar & Company Ltd planning capital expenditure?

- The company has completed major investments in development and production capacities for its Flavours business and expects this phase to be finished for the current size. - Further investments in the Flavours business are anticipated in the next 2 years to support continued growth. - Recent investments include setting up creative development centers in Europe (UK and Germany) and the USA, focusing on product development teams to serve local and global MNC markets. - Capital expenditure of around Rs.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.